Does Dr. DANNY ABDALLAH SAMARA have financial conflicts of interest?

Dr. DANNY ABDALLAH SAMARA (MD) has received a total of $1,006 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,006 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DANNY ABDALLAH SAMARA?

According to CMS Open Payments data, Dr. DANNY ABDALLAH SAMARA received funding from BAYER HEALTHCARE PHARMACEUTICALS ($390), ASTRAZENECA PHARMACEUTICALS ($233), and AMGEN ($137).

Does Dr. DANNY ABDALLAH SAMARA receive research grants or speaking fees?

Dr. DANNY ABDALLAH SAMARA has received $1,006 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. DANNY ABDALLAH SAMARA

MDReal-Time Hydrated

Specialty: General Practice

Practice Location: OCALA, FL 34481

NPI Number: 1740826635

LIFETIME INDUSTRY VALUE

$1,006

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABDALLAH SAMARA is a verified General Practice practitioner based in OCALA, FL.

Between 2021 and 2025, Dr. ABDALLAH SAMARA had an overall industry promotional and research financial footprint of $1,006 as recorded in the federal CMS Open Payments database.

$1,006 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDALLAH SAMARA's primary funding source is BAYER HEALTHCARE PHARMACEUTICALS, which accounts for $390 (representing 38.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BAYER HEALTHCARE PHARMACEUTICALS

Rank 1

$390

38.8%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$233

23.1%

AMGEN

Rank 3

$137

13.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.